Delivery Order SPE2DR25D3103-SPE2DR26F9M29
- Not listed
- This delivery order, awarded August 1, 2025, to AmerisourceBergen Drug Corp provides Protamine 50 mg/5 mL vials with a ceiling value of $1,078.10 and a completion date of August 4, 2025. The award was made without a set-aside designation through a competitive process by the Defense Logistics Agency's Medical Supply Chain on behalf of the Defense Department. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The Defense Logistics Agency awarded a $158 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562125875 protamine 10 mg/ml vials. As the prime contractor, Amerisourcebergen will deliver 25 ml vials of the pharmaceutical product from its Conshohocken, Pennsylvania facility by September 12, 2023 in support of DLA programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of PROTAMINE 5ML INJ 25S, a pharmaceutical product, with a ceiling value of $2,969.40 and a period of performance through September 20, 2024. This contract is not set-aside. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, supporting various...
- This federal contract award to Amerisourcebergen Drug Corporation, valued at $2,542.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of PROTAMINE 50 MG/5 ML VIAL 5ML, a critical pharmaceutical product, to support military treatment facilities and other government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- The Defense Logistics Agency (DLA) awarded a $2,578.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Heparin Sodium 5,000 Unit/0.5 mL pharmaceutical product. This is a non-set-aside award issued on November 27, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,371.36 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Heparin 10,000 Unit/10 mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 29, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used in this award. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Protopam Chloride 1 GM vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,540.93 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 Unit/250 mL in 5% Dextrose Water (D5W) solution, with a ceiling value of $1,061.90. This competitive, firm fixed-price delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Heparin Sodium 5,000 Unit/0.5 mL injections with a ceiling value of $4,419.10. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,324.59 to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 unit/250 ml in D5W solution (250 ml units). This firm fixed-price delivery order, awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation,...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9M29Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,527.30 to AmerisourceBergen Drug Corp for Protamine 50 mg/5 mL vials on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order is unclassified as a set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Protamine is a pharmaceutical product used clinically to reverse the anticoagulant effects of heparin, making it essential for military and federal healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's broad portfolio of pharmaceutical products and medical supplies—including specialty medications, vaccines, and medical devices across multiple therapeutic domains—enables it to fulfill diverse medical procurement requirements through open competitive bidding.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/4/25 |